Entero Healthcare grows revenue 29.6% to ₹6,591 crore in FY26
The healthcare distributor posted a 35.6% jump in profit for the year, alongside a minor bolt-on acquisition of two surgical firms.
— 2 earlier stories on Entero Healthcare Solutions Ltd. →What's new
- FY26 revenue reached ₹6,591 crore, up 29.6% year-on-year.
- Profit after tax climbed 35.6% to ₹146 crore.
- The board approved the acquisition of two surgical distribution firms for ₹9.2 crore.
Why this matters
The results show consistent growth driven by both organic expansion and acquisitions. The latest bolt-on deal is immaterial to the company's ₹5,887 crore market cap, confirming this is a routine disclosure of expected financial performance.
What we're watching
- Integration progress of the newly acquired surgical distribution firms.
- Sustainability of the 35.6% profit growth rate in the coming year.
- Future acquisition pipeline given the company's inorganic growth strategy.
The full read
Entero Healthcare Solutions closed FY26 with consolidated revenue of ₹6,591 crore, a 29.6% increase over the prior year. Profit after tax grew by 35.6% to ₹146 crore, reflecting the company's ongoing reliance on both organic growth and acquisitions.
It is steady work.
Alongside the financial results, the board approved the purchase of two surgical distribution firms for a total of ₹9.2 crore. Given the company's market cap of ₹5,887 crore, this deal is immaterial, and the filing also covered routine governance items including director reappointments and ESOP grants that offer no surprises for investors.
Questions answered
- What were the key financial results for Entero Healthcare in FY26?
- The company reported consolidated revenue of ₹6,591 crore, representing a 29.6% increase. Profit after tax rose by 35.6% to reach ₹146 crore.
- How significant is the new acquisition mentioned in the filing?
- The acquisition of two surgical distribution firms for up to ₹9.2 crore is immaterial. It represents a tiny fraction of the company's ₹5,887 crore market capitalization.
- Are there any other material updates in the board meeting outcome?
- No. Other items such as director reappointments and ESOP grants are routine administrative matters with no price-sensitive impact.
Story so far
All notes on ENTERO →- 25 May 2026 · 9:07 PM IST Entero Healthcare grows revenue 29.6% to ₹6,591 crore in FY26
- today Entero Healthcare reports 30% revenue growth in FY26
- today Entero Healthcare revenue grows 29.6% to ₹6,591 crore in FY26